AzTrials
AzTrials

Procedural PainNCT07739381

Effects of Virtual Reality and Tablet Distraction During IV Cannulation in Children

A study testing Virtual Reality Distraction and Tablet Distraction in people with Procedural Pain and Anxiety, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial was conducted to evaluate the effects of virtual reality and tablet-based audiovisual distraction on pain, anxiety, and fear in children undergoing intravenous cannulation in a pediatric emergency department. Read more about this study

Who is it for?
Ages 7 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Procedural Pain, Anxiety, Fear
What is being tested?
Virtual Reality Distraction and Tablet Distraction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2022to 1 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • It was that the child belonged to the 7-12 age group and was fully conscious.

Who cannot join

  • Children with hearing, cognitive, or visual impairments; children unaccompanied by a parent; children with whom communication cannot be established; and children with critical health issues and/or conditions requiring immediate intervention.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kütahya Evliya Çelebi Training and Research Hospital

    Kütahya, Kütahya, 4300

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Watching an Entertaining Video With Virtual Reality Glasses and a Tablet on Pain, Anxiety, and Fear During Intravenous Cannulation in Children in the Emergency Department: A Randomized Controlled Trial

This randomized controlled trial was conducted to evaluate the effects of virtual reality and tablet-based audiovisual distraction on pain, anxiety, and fear in children undergoing intravenous cannulation in a pediatric emergency department. Children aged 7 to 12 years were randomly assigned to three groups: virtual reality, tablet, and control. During intravenous cannulation, children in the virtual reality group watched an entertaining video using a virtual reality headset, while children in the tablet group watched the same video on a tablet. Children in the control group received routine care without an audiovisual distraction intervention. Pain, anxiety, and fear were assessed using age-appropriate validated scales. The study compared the effects of the two distraction methods with routine care and with each other.

Read the detailed description

The study was designed as a randomized controlled trial involving children aged 7 to 12 years who required intravenous cannulation in a pediatric emergency department. Eligible participants were randomly assigned in a 1:1:1 ratio to a virtual reality group, a tablet group, or a control group.

Children assigned to the virtual reality group watched an entertaining audiovisual video using a virtual reality headset during intravenous cannulation. Children assigned to the tablet group watched the same video on a tablet during the procedure. Children in the control group underwent intravenous cannulation according to the routine clinical practice of the emergency department without an audiovisual distraction intervention.

Anxiety and fear were assessed immediately before intravenous cannulation and again five minutes after the procedure. Pain was assessed immediately after intravenous cannulation. The primary purpose of the study was to determine whether virtual reality and tablet-based distraction reduced procedure-related pain, anxiety, and fear and to compare the effectiveness of these interventions.

Being tested
Virtual Reality Distraction, Tablet Distraction
Keywords
virtual reality, tablet, children, fear, anxiety
Medical subject headings
Pain, Procedural, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality DistractionBehavioural

    Children in the virtual reality group received virtual reality-based distraction during intravenous cannulation. A virtual reality headset was used to divert the child's attention from the procedure.

  • Tablet DistractionBehavioural

    Children in the tablet group watched an age-appropriate cartoon on a tablet during intravenous cannulation to divert their attention from the procedure.

Study groups in NCT07739381
Study groupRoleWhat they receive
Virtual Reality GroupExperimentalChildren watched an age-appropriate entertaining video using a virtual reality headset during intravenous cannulation.
Receives: Behavioral: Virtual Reality Distraction
tablet GroupExperimentalChildren watched the same age-appropriate entertaining video on a tablet during intravenous cannulation.
Receives: Behavioral: Tablet Distraction
control groupNo interventionChildren underwent intravenous cannulation according to routine clinical practice without any audiovisual distraction intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain During Intravenous Cannulation

    Pain intensity was assessed using the Wong-Baker FACES Pain Rating Scale. The scale consists of six facial expressions representing increasing levels of pain. Scores range from 0 to 10, with higher scores indicating greater pain intensity. Pain was assessed immediately after intravenous cannulation.

    Measured: Immediately after intravenous cannulation

Secondary outcomes (1)
  1. Anxiety Before and After Intravenous Cannulation

    Anxety was assesed using the scale .Higher scores indicate greater anxiety.

    Measured: Immediately before and immediately after intravenous cannulation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2026
  2. Study start1 Apr 2022
  3. Primary completion1 Aug 2022
  4. Study completion1 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned in a 1:1:1 ratio to the virtual reality, tablet, or control group.
Masking
None (open label)
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07739381
Sponsor's protocol ID
2021/284
Status last verified
Jul 2026
First submitted
28 Jul 2026
Last updated
31 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Distraction and Tablet Distraction in people with Procedural Pain and Anxiety, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain During Intravenous Cannulation (time frame: Immediately after intravenous cannulation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in